Collaborations Can Make UK a Pharma Leader
The Pharma Letter website reported that the move away from the older model of closed corporate research and development labs and towards collaborative working and open innovation is highlighted as in the R&D sourcebook from the Association of the British Pharmaceutical Industry (ABPI). “It is therefore vital for the future discovery and development of medicines that we continue to collaborate and explore outside of our companies, industry and sector. By focusing on open innovation, this sourcebook aims to shed light on the complex, changing face of the pharmaceutical industry,” said Neil Weir, chairman of the ABPI Innovation Board.
Click here to read the full article.